THE Kano State office of the National Agency for Food and Drug Administration and Control on Sunday said it had arrested some suspects, adding that two persons were directly implicated in the distribution of Dan Tsami, the killer juice in the state.
The NAFDAC Coordinator in Kano, Dr Mohamed Shaba, in a terse press statement made available to The PUNCH disclosed that stakeholders had worked collaboratively to create public awareness on the consumption of dangerous, which might be mistaken for something else.
“We made arrest of some individuals implicated in the unfortunate incident and two individuals directly connected with the distribution of Dan Tsami,” he said
However, Shaba, promised that NAFDAC would continue with its routine surveillance on the supply chain and the trade, meet with stakeholders meeting and enlightenment of chemicals marketers and importers.
Agency identifies dangerous chemical in Kano killer juice
Meanwhile, NAFDAC has identified hydroxylamine sulphate as the killer chemical used in brewing Dan Tsami local juice, which has so far claimed 10 lives, while majority of the 400 people earlier hospitalized have been treated and discharged.
The Kano State Executive Secretary, Primary Health Development Authority, Dr Hussain Tijjani, who confirm this to The PUNCH in Kano on Sunday, said, “On the analysis report (of NAFDAC), the chemical identified is hydroxylamine sulphate.
Earlier, Tijjani had quoted the state Health Commissioner, Dr Aminu Tsanyawa’s press statement, noting that 400 persons were hospitalised, most of whom had been discharged, while about 10 deaths were recorded, at the peak of the outbreak of the incident.
“About 50 patients have undergone dialysis following the ingestion of the substance,” he said.
It was learnt that the locally brewed juice affected the kidney of the victims, a development that informed the need for some of them to undergo blood transfusion.
Though our correspondent could not find any of the hospitalised victims on their sick bed, it was learnt that the over 50 patients, whose ages ranged from five to 20 years, had been treated and discharged.
According to a source, who preferred anonymity, some of the patients, whose condition was severe, received blood transfusion while other categories of patients were administered with drugs.